已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response

内型 医学 美波利祖马布 重症监护医学 精密医学 哮喘 苯拉唑马布 微生物群 鉴定(生物学) 机制(生物学) 生物信息学 免疫学 嗜酸性粒细胞 病理 生物 植物 哲学 认识论
作者
José Gurrola,Larry Borish
出处
期刊:The Journal of Allergy and Clinical Immunology [Elsevier BV]
卷期号:140 (6): 1499-1508 被引量:108
标识
DOI:10.1016/j.jaci.2017.10.006
摘要

It is increasingly recognized that chronic rhinosinusitis (CRS) comprises a spectrum of different diseases with distinct clinical presentations and pathogenic mechanisms. Defining the distinct phenotypes and endotypes of CRS affects prognosis and, most importantly, is necessary as the basis for making therapeutic decisions. The need for individualized definitions of pathogenic mechanisms before initiating therapy extends to virtually all therapeutic considerations. This is clearly crucial with antibiotics, where, barring an influence from their off-target anti-inflammatory pharmacologic effects, an understanding of the role of the individual biome predicts likelihood of therapeutic benefit. However, this need for identifying individual phenotypes and endotypes also extends to the agent that is currently considered the mainstay of treatment of CRS, specifically glucocorticoids. As with asthma, it is recognized that a large minority of patients with CRS have a steroid-resistant phenotype, identification of which will preclude use of these agents with their potential side effects. Identification of endotypes is also becoming increasingly imperative because targeted biotherapeutic agents, such as anti-IgE and anti-cytokine antibodies, are becoming available. These agents are likely to benefit patients in whom the targeted mediator is not only expressed but demonstrably driving a central mechanism in that patient. In summary, the treatment of CRS is at an exciting crossroad. On the positive side, numerous therapeutics are in development that seem likely to have a positive effect in our patients with this condition. The challenge is that these therapies will require targeted individualized treatments based on identifying subjects with the relevant endotype.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
5秒前
一只熊完成签到 ,获得积分10
5秒前
rpe完成签到,获得积分20
6秒前
星辰大海应助鸽子爱好者采纳,获得10
12秒前
nan完成签到,获得积分10
12秒前
柔弱熊猫完成签到 ,获得积分10
13秒前
CC发布了新的文献求助10
14秒前
lh完成签到 ,获得积分10
15秒前
19秒前
冷静傲丝完成签到 ,获得积分10
22秒前
sigrid完成签到,获得积分10
23秒前
包子完成签到,获得积分10
24秒前
wbqdssl完成签到 ,获得积分10
28秒前
知足的憨人*-*完成签到,获得积分10
30秒前
momo应助桀桀桀采纳,获得10
30秒前
azhou176完成签到,获得积分10
31秒前
lucky完成签到 ,获得积分10
31秒前
丸子完成签到 ,获得积分10
31秒前
chestnut灬完成签到 ,获得积分10
32秒前
01259完成签到 ,获得积分10
32秒前
喜悦香薇完成签到 ,获得积分10
32秒前
35秒前
1230完成签到 ,获得积分10
36秒前
37秒前
Rondab应助科研通管家采纳,获得10
37秒前
领导范儿应助科研通管家采纳,获得10
37秒前
在水一方应助科研通管家采纳,获得10
37秒前
37秒前
白桦林泪完成签到,获得积分10
38秒前
yangzai完成签到 ,获得积分10
39秒前
41秒前
自然千山完成签到,获得积分10
41秒前
Augusterny完成签到 ,获得积分10
42秒前
YBR完成签到 ,获得积分10
43秒前
hellokitty发布了新的文献求助10
44秒前
白桦林泪发布了新的文献求助20
44秒前
44秒前
懵懂的冰凡完成签到,获得积分10
45秒前
知足的憨人丫丫完成签到,获得积分10
45秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989972
求助须知:如何正确求助?哪些是违规求助? 3532034
关于积分的说明 11256042
捐赠科研通 3270884
什么是DOI,文献DOI怎么找? 1805093
邀请新用户注册赠送积分活动 882256
科研通“疑难数据库(出版商)”最低求助积分说明 809216